PortfoliosLab logoPortfoliosLab logo
HSDT vs. SOL-USD
Performance
Return for Risk
Drawdowns
Volatility

Performance

HSDT vs. SOL-USD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Helius Medical Technologies, Inc. (HSDT) and Solana (SOL-USD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both investments are quite close, with HSDT having a -40.83% return and SOL-USD slightly higher at -39.45%.


HSDT

1D
-2.29%
1M
11.04%
6M
-46.73%
YTD
-40.83%
1Y
-78.76%
3Y*
-93.73%
5Y*
-92.24%
10Y*
-74.35%

SOL-USD

1D
-1.98%
1M
9.38%
6M
-45.80%
YTD
-39.45%
1Y
-53.26%
3Y*
41.32%
5Y*
19.17%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

HSDT vs. SOL-USD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
HSDT
Helius Medical Technologies, Inc.
-40.83%-99.43%-91.66%-47.61%-94.09%-60.63%43.19%
SOL-USD
Solana
-39.45%-34.09%85.68%919.96%-94.13%11,143.63%81.60%

Correlation

The correlation between HSDT and SOL-USD is 0.44, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.44

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.16

Correlation (All Time)
Calculated using the full available price history since Apr 10, 2020

0.13

Over the past year, HSDT and SOL-USD have become more correlated (0.44) than their long-term average of 0.13, meaning their price movements have been converging.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HSDT vs. SOL-USD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HSDT
HSDT Risk / Return Rank: 2222
Overall Rank
HSDT Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
HSDT Sortino Ratio Rank: 2626
Sortino Ratio Rank
HSDT Omega Ratio Rank: 2727
Omega Ratio Rank
HSDT Calmar Ratio Rank: 1111
Calmar Ratio Rank
HSDT Martin Ratio Rank: 2222
Martin Ratio Rank

SOL-USD
SOL-USD Risk / Return Rank: 5858
Overall Rank
SOL-USD Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
SOL-USD Sortino Ratio Rank: 5454
Sortino Ratio Rank
SOL-USD Omega Ratio Rank: 5555
Omega Ratio Rank
SOL-USD Calmar Ratio Rank: 6767
Calmar Ratio Rank
SOL-USD Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HSDT vs. SOL-USD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Helius Medical Technologies, Inc. (HSDT) and Solana (SOL-USD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HSDTSOL-USDDifference
Sharpe ratioReturn per unit of total volatility

+0.32

Sortino ratioReturn per unit of downside risk

+0.66

Omega ratioGain probability vs. loss probability

0.96

0.91

+0.06

Calmar ratioReturn relative to maximum drawdown

-0.83

-0.71

-0.12

Martin ratioReturn relative to average drawdown

-1.02

-1.05

+0.03

HSDT vs. SOL-USD - Sharpe Ratio Comparison

The current HSDT Sharpe Ratio is -0.43, which is higher than the SOL-USD Sharpe Ratio of -0.74. The chart below compares the historical Sharpe Ratios of HSDT and SOL-USD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HSDT vs. SOL-USD - Drawdown Comparison

The maximum HSDT drawdown since its inception was -100.00%, roughly equal to the maximum SOL-USD drawdown of -96.27%. Use the drawdown chart below to compare losses from any high point for HSDT and SOL-USD.


Loading charts...

Drawdown Indicators


HSDTSOL-USDDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-96.27%

-3.73%

Max Drawdown (1Y)

Largest decline over 1 year

-94.74%

-74.89%

-19.85%

Max Drawdown (3Y)

Largest decline over 3 years

-99.98%

-76.28%

-23.70%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

-96.27%

-3.73%

Max Drawdown (10Y)

Largest decline over 10 years

-100.00%

Current Drawdown

Current decline from peak

-100.00%

-71.24%

-28.76%

Average Drawdown

Average peak-to-trough decline

-73.58%

-51.69%

-21.89%

Ulcer Index

Depth and duration of drawdowns from previous peaks

77.19%

42.68%

+34.51%

Volatility

HSDT vs. SOL-USD - Volatility Comparison

Helius Medical Technologies, Inc. (HSDT) has a higher volatility of 29.01% compared to Solana (SOL-USD) at 15.11%. This indicates that HSDT's price experiences larger fluctuations and is considered to be riskier than SOL-USD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HSDTSOL-USDDifference

Volatility (1M)

Calculated over the trailing 1-month period

29.01%

15.11%

+13.90%

Volatility (6M)

Calculated over the trailing 6-month period

71.01%

47.74%

+23.27%

Volatility (1Y)

Calculated over the trailing 1-year period

184.71%

59.43%

+125.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

156.90%

81.36%

+75.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

200.01%

99.29%

+100.72%

Frequently Asked Questions


HSDT and SOL-USD have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HSDT has higher volatility (29.01%) compared to SOL-USD (15.11%). In terms of maximum drawdown, HSDT dropped -100.00% vs SOL-USD's -96.27%.

HSDT currently has the higher Sharpe Ratio (-0.43 vs -0.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HSDT and SOL-USD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer